The Evidence
Does CBD help arthritis pain?
TL;DR — What the Evidence Shows
Controlled clinical trials have not found that CBD relieves arthritis pain. Three studies tested CBD specifically for osteoarthritis. None found a clear benefit over a placebo.
Many people report that CBD helps their pain. Controlled studies have not confirmed this.
How certain is the evidence?
Each row below rates a specific outcome. Ratings follow the GRADE framework and attach to one finding, not to CBD overall.
| Outcome | Certainty | What the evidence says |
|---|---|---|
| CBD for osteoarthritis pain relief | Very Low Certainty | The evidence is very uncertain about whether CBD results in pain relief for osteoarthritis. |
| CBD for osteoarthritis inflammation (human) | Very Low Certainty | The evidence is very uncertain about whether CBD reduces joint inflammation in humans with osteoarthritis. No human trial has measured joint-specific biomarkers. |
| CBD for osteoarthritis physical function | Very Low Certainty | The evidence is very uncertain about whether CBD improves physical function in osteoarthritis. Trials found no significant effect. |
Ratings follow GRADE methodology. How we rate evidence.
What did the osteoarthritis-specific trials find?
Three randomized controlled trials have tested CBD specifically for osteoarthritis pain. All three were double-blind studies where participants did not know whether they received CBD or a placebo.
Vela et al. 2022
- 136 participants with knee osteoarthritis
- 50 mg per day of CBD gel capsules for 12 weeks
- Randomized, double-blind, placebo-controlled
- Result: No significant difference between CBD and placebo. The difference on a 100-point pain scale was 0.23 points — meaning the true difference could be anything from slightly worse to slightly better. Essentially, no detectable effect.
Bialas et al. 2023
- 86 participants with knee osteoarthritis
- Oral CBD added to paracetamol (acetaminophen)
- Randomized, double-blind, placebo-controlled
- Result: No significant pain improvement. No significant difference on the WOMAC questionnaire.
CANOA / Mojoli et al. 2025
- Participants with knee osteoarthritis
- CBD-rich Cannabis sativa oil
- Randomized, placebo-controlled
- Result: No significant benefit for pain over placebo.
What do the broader reviews say?
Moore et al. 2024 — CBD pain trials review
This review examined 16 randomized controlled trials testing CBD specifically (not other cannabis products) for pain.
Result: 15 out of 16 CBD pain trials found no significant benefit over placebo. The authors concluded that CBD products for pain are "ineffective, expensive, and with potential harms."
AHRQ 2025 — Living systematic review
The Agency for Healthcare Research and Quality reviewed 25 randomized controlled trials (2,303 participants) on cannabis-based treatments for chronic pain.
Result: CBD alone was not associated with decreased pain intensity.
What about the positive studies you may have seen?
Many news articles and product websites cite animal research showing that CBD reduces inflammation. These findings are real, but they come from a different type of study.
Animal studies
In rat models of arthritis, CBD applied to the skin reduced joint swelling and pain-related behaviors (Hammell 2016) (Philpott 2017). These are scientifically valid findings within their context.
However, only about 1 out of 20 treatments that work in animals end up working in humans (Ineichen 2024). When three human trials tested CBD for arthritis pain, none found a benefit.
Survey data tells a different story than the clinical trials. In the Arthritis Foundation's 2019 survey of 2,600 people, about 65 to 80 out of 100 respondents reported that CBD improved their pain. Human Survey
This gap between what people report and what controlled trials find is common in pain research. Without a placebo comparison, survey results cannot distinguish real drug effects from expectation effects. A 2022 analysis found that media attention about cannabis therapies was linked to higher placebo response rates in pain trials (Gedin 2022).
This does not mean that the relief people report is imaginary. Placebo effects produce real changes in how the brain processes pain. But it does mean we cannot confirm from survey data alone that CBD was the cause. Learn more about animal vs. human studies.
What do we not know?
- Optimal dosing. The three osteoarthritis trials tested different doses (ranging from 20 to 600 mg per day). No study has been designed specifically to determine the most effective dose for arthritis. It is possible that untested doses could produce different results.
- bioavailability. Oral CBD has about 6 out of 100 bioavailability in humans, meaning the body absorbs very little of what is swallowed. Whether different delivery methods (topical or sublingual) could change outcomes is not established in osteoarthritis trials.
- Formulation differences. CBD products vary widely in quality, actual CBD content, and other ingredients. The trials used pharmaceutical-grade CBD. Whether commercial products would produce the same or different results is unknown.
- Individual variation. Some people may metabolize CBD differently due to genetics or other medications. Whether a subgroup of patients might benefit has not been studied.
- Topical CBD for larger joints. One very small trial (18 participants, 2 weeks) found a positive result for topical CBD on thumb joints. This has not been replicated, and whether it applies to knee or hip osteoarthritis is unknown.
- Long-term effects. The longest osteoarthritis trial was 12 weeks. Long-term effectiveness and safety for arthritis use have not been studied.
CBD interacts with many common medications
- Blood thinners (warfarin): CBD can increase bleeding risk by raising INR levels
- Statins, blood pressure medications, and immunosuppressants may also be affected
- CBD blocks the same liver enzymes that process many prescription drugs
Based on cited sources. This is not personalized medical advice — discuss with your healthcare provider.
Full drug interaction guide, medication checker, and pharmacist discussion checklist.
Key sources cited on this page
Page last reviewed: March 2026 · Authored by Claude (Anthropic AI) · Research methodology